Lopressor: Difference between revisions

Metoprolol
Clinical data
Trade names	Lopressor, Toprol-xl
AHFS/Drugs.com	Monograph
MedlinePlus	a682864
[[Regulation of therapeutic goods \|Template:Engvar data]]	US FDA: Metoprolol;
Pregnancy; category	AU: C ; US: C (Risk not ruled out) ; ;
Routes of; administration	Oral, IV
ATC code	C07AB02 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Pharmacokinetic data
Bioavailability	12%
Metabolism	Hepatic via CYP2D6, CYP3A4
Elimination half-life	3-7 hours
Excretion	Renal
Identifiers
	IUPAC name (RS)-1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol;
CAS Number	51384-51-1 ;
PubChem CID	4171;
IUPHAR/BPS	553;
DrugBank	DB00264 ;
ChemSpider	4027 ;
UNII	GEB06NHM23;
KEGG	D02358 ;
ChEBI	CHEBI:6904 ;
ChEMBL	ChEMBL13 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C15H25NO3
Molar mass	267.364 g/mol
3D model (JSmol)	Interactive image;
Melting point	120 °C (248 °F)
	SMILES O(c1ccc(cc1)CCOC)CC(O)CNC(C)C;
	InChI InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3 ; Key:IUBSYMUCCVWXPE-UHFFFAOYSA-N ;
(verify)

VisualWikitext

Revision as of 16:05, 17 March 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

For information about metoprolol, click here.

Disclaimer

Black Box Warning

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Off-Label Use and Dosage (Adult)

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Off-Label Use and Dosage (Pediatric)

Dose Adjustments

Pregnancy

Labor and Delivery

Nursing Mothers

Pediatric Use

Geriatric Use

Gender

Race

Renal Impairment

Hepatic Impairment

Females of Reproductive Potential and Males

Immunocompromised Patients

FDA-Labeled Indications

Off-Label Use

Contraindications

Dosage Forms and Strengths

Indications and Usage

Warnings and Precautions

Adverse Reactions

Drug Interactions

Use in Specific Populations

Overdosage

Description

Mechanism of Action

Clinical Pharmacology

Nonclinical Toxicology

Clinical Studies

How Supplied/Storage and Handling

Patient Counseling Information

Labels and Packages

Pill Images and Characteristics

Price

Look-Alike Drug Names

@@ Line 26: / Line 26: @@
 ===[[Lopressor dose adjustments#Labor and Delivery|Labor and Delivery]]===
 ===[[Lopressor dose adjustments#Nursing Mothers|Nursing Mothers]]===
 ===[[Lopressor dose adjustments#Pediatric Use|Pediatric Use]]===
 ===[[Lopressor dose adjustments#Geriatric Use|Geriatric Use]]===
 ===[[Lopressor dose adjustments#Gender|Gender]]===
 ===[[Lopressor dose adjustments#Race|Race]]===
 ===[[Lopressor dose adjustments#Renal Impairment|Renal Impairment]]===
 ===[[Lopressor dose adjustments#Hepatic Impairment|Hepatic Impairment]]===
 ===[[Lopressor dose adjustments#Females of Reproductive Potential and Males|Females of Reproductive Potential and Males]]===
 ===[[Lopressor dose adjustments#Immunocompromised Patients|Immunocompromised Patients]]===
 ==[[Lopressor FDA-labeled indications|FDA-Labeled Indications]]==
 ==[[Lopressor Off-label use|Off-Label Use]]==
+==[[Lopressor contraindications|Contraindications]]==
@@ Line 68: / Line 57: @@
 ==[[Lopressor dosage forms and strengths|Dosage Forms and Strengths]]==
 ==[[Lopressor indications and usage|Indications and Usage]]==
-==[[Lopressor contraindications|Contraindications]]==
 ==[[Lopressor warnings and precautions|Warnings and Precautions]]==
 ==[[Lopressor adverse reactions|Adverse Reactions]]==

Lopressor: Difference between revisions

Revision as of 16:05, 17 March 2014

Navigation menu